<DOC>
	<DOCNO>NCT03105362</DOCNO>
	<brief_summary>This study assess tolerability palatability amino acid base oral rehydration solution ( enterade® ) compare current oral rehydration solution among child short bowel syndrome .</brief_summary>
	<brief_title>Amino Acid-based Oral Rehydration Solution Children With Short Bowel Syndrome</brief_title>
	<detailed_description>Patients short bowel syndrome ( SBS ) critical reduction gut mass/function minimum need absorb nutrient fluid require adequate homeostasis . There limited data regard optimal choice oral rehydration set SBS maximize fluid absorption set diarrhea limit intestinal absorptive surface area . The investigator propose preliminary open label single center study assess tolerability palatability enterade® ( amino acid ( AA ) base oral rehydrating solution ( ORS ) ) compare baseline . Eligible patient SBS participate 14-day trial monitoring measure tolerability palatability AA-ORS , enterade® , addition regular diet .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Male female patient diagnosis short bowel syndrome ( defined surgical therapy congenital acquire gastrointestinal disease ) age 117 Patients intestinal continuity divert ileostomy , jejunostomy Patients must stable enteral nutrition regimen oral rehydration fluid take orally . Stable GI medication regimen ( e.g. , loperamide , cholestyramine , small bowel bacterial overgrowth ( SBBO ) regimen ) Patients receive IV antibiotic within previous 72h . Patients primary diagnosis motility disorder ( e.g. , chronic intestinal pseudoobstruction ) epithelial cell disorder ( e.g. , microvillus inclusion disease ) Malnourished ( define Weight/Height Zscore ( WHZ ) &lt; 2 )</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Oral Rehydration Solutions</keyword>
</DOC>